NPS and diabetes mellitus: Second, as they stated in their analysis that they did not record the somatic symptom in their subjects, as the interference of chronic somatic disorders such as diabetes, cardiovascular diseases, endocrinological problems, and their specific pharmacological treatment might have affected plasma neuropeptide levels.